TGF-β in Cancer: Metabolic Driver of the Tolerogenic Crosstalk in the Tumor Microenvironment
Overcoming tumor immunosuppression still represents one ambitious achievement for cancer immunotherapy. Of note, the cytokine TGF-β contributes to immune evasion in multiple cancer types, by feeding the establishment of a tolerogenic environment in the host. Indeed, it fosters the expansion and accu...
Main Authors: | Roberta Angioni, Ricardo Sánchez-Rodríguez, Antonella Viola, Barbara Molon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/3/401 |
Similar Items
-
TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment
by: Jeff Yat-Fai Chung, et al.
Published: (2021-07-01) -
TGFβ Signaling in the Pancreatic Tumor Microenvironment
by: Daniel R. Principe, et al.
Published: (2021-10-01) -
Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment
by: Nicholas F. Brown, et al.
Published: (2019-08-01) -
TGFβ and the Tumor Microenvironment in Colorectal Cancer
by: Maximilian J. Waldner, et al.
Published: (2023-04-01) -
Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis
by: Rasmus S. Pedersen, et al.
Published: (2022-09-01)